|1||NCT02809079||Unknown †||Mycophenolate Mofetil Treatment With Neuromyelitis Optica Spectrum Disorders in Chinese Patients||
||100||All||18 Years to 65 Years (Adult, Older Adult)||NCT02809079||2016017||MONICA||January 2016||December 2017||December 2017||June 22, 2016||June 22, 2016|
|2||NCT02028884||Active, not recruiting||Efficacy and Safety Study of Satralizumab (SA237) as Add-on Therapy to Treat Participants With Neuromyelitis Optica (NMO) and NMO Spectrum Disorder (NMOSD)||
||83||All||12 Years to 74 Years (Child, Adult, Older Adult)||NCT02028884||BN40898
|February 20, 2014||June 6, 2018||March 31, 2021||January 7, 2014||September 6, 2019||
† Study has passed its completion date and status has not been verified in more than two years.